Current Scenario in Structure and Ligand-Based Drug Design on Anti-colon Cancer Drugs

Area of Science:

• Computational chemistry and molecular modeling.
• Drug discovery and medicinal chemistry.
• Oncology and cancer research.

Background:

• Colorectal cancer is a leading cause of cancer incidence and mortality globally.
• Molecular modeling has significantly advanced drug discovery through structure- and ligand-based methods.
• Understanding molecular and quantum mechanics is crucial for effective anticancer drug design.

Purpose of the Study:

• To highlight key aspects of anticancer drug design.
• To discuss structure- and ligand-based drug design strategies.
• To present recent advances in identifying anticancer agents using computational insights.

Main Methods:

• Review of molecular modeling studies.
• Analysis of structure-based drug design principles.
• Investigation of ligand-based drug design methodologies.
• Exploration of quantum mechanics in anti-cancer drug development.

Main Results:

• Significant progress in drug discovery using molecular modeling techniques.
• Identification of anticancer agents driven by structural and molecular insights.
• Discussion of the current landscape and recent advancements in cancer drug design.

Conclusions:

• Computational power is revolutionizing cancer drug formulation and identification.
• Structure- and ligand-based design methods are pivotal in developing novel anticancer therapeutics.
• The study provides insights into the computational approaches employed by the drug discovery society for cancer drugs.